A deadly, drug-resistant fungus, Candida auris, is spreading globally, with 7,000 US cases in 2025. Researchers warn of limited treatments but see hope in new studies targeting its biology.
ERBIL (Kurdistan24) — A deadly and…
Category: 6. Health
-
When measles made a comeback in Mesa County | Western Colorado
It was a comeback year in 2025 in many ways, from the resurgence of ’90s fashion, such as bootcut jeans and denim-on-denim, to the return of wired headphones.
But 2025 also saw the revival of less desirable relics, like the measles, which…
Continue Reading
-
AgenT-797 (iNKT): What Patients Need to Know About This New Cancer Immunotherapy
AgenT-797 is an experimental cancer treatment being studied in clinical trials. It belongs to a newer category of treatments called cellular immunotherapy, which uses immune cells to help the body recognize and fight cancer….
Continue Reading
-
AgenT-797 (iNKT): Uses in Cancer, Side Effects, Dosages, Expectations, and Clinical Trial Evidence
Cellular immunotherapy has traditionally centered on autologous, genetically engineered T-cell platforms, which—despite transformative efficacy in selected settings—are limited by toxicity, manufacturing complexity, and…
Continue Reading
-
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026
Liver cancer treatment has evolved significantly over the past two decades, and tumor ablation has become an important option for selected patients—especially those diagnosed at an early stage. For many people who are not…
Continue Reading
-
Ban on adverts for ‘less healthy food’ set to come into full effect
A crackdown on advertising for unhealthy food comes into full effect on Monday in a bid to tackle childhood obesity.
The ban prevents ads for “less healthy” food and drink that is high in fat, salt and sugar (HFSS) appearing on television…
Continue Reading
-
Breakthrough obesity drugs are here but not for everyone
Access to obesity treatment in the UK may be heading toward a two-tier system, raising concerns that some of the most vulnerable patients could be left without help. Researchers warn that people who cannot afford private care may struggle to…
Continue Reading
-
Shanghai student becomes 1st hematopoietic stem cell donor of 2026
Twenty-two-year-old university student, Li Zhenglin, is the first hematopoietic stem cell donor of the year in Shanghai on Thursday. [Photo provided to chinadaily.com.cn]
A 22-year-old graduate student…
Continue Reading
-
Shanghai student becomes 1st hematopoietic stem cell donor of 2026
Twenty-two-year-old university student, Li Zhenglin, is the first hematopoietic stem cell donor of the year in Shanghai on Thursday. [Photo provided to chinadaily.com.cn]
A 22-year-old graduate student…
Continue Reading
-
Resectable Esophageal Adenocarcinoma: A Comparative Analysis of Divergent Outcomes With FLOT and CROSS in Trial and Real-World Settings
Esophageal adenocarcinoma is an aggressive malignancy with rising incidence and high mortality, for which multimodal treatment is standard in resectable disease. Surgery alone is insufficient, and combined systemic and…
Continue Reading